Aesica Pharmaceuticals GmbH

Arzneimittelproduktion - Schwerpunkte in den Bereichen Herz-Kreislauf, Magen-Darm, Asthma, Neurologie und Urologie; Granulate, Tabletten, Filmtabletten, Pellets, Kapseln Bulk production site excelling in solid dosage forms and offering a full spectrum of analytical and development capabilities. Multi-purpose site for: 3 billion+ capacity, 98 bulk products, 12 APIs, Pellet production, Hard gelatine capsules, Analytical and development capabilities, Authority approvals include: EU, FDA, Korean FDA, PDMA, ANVISA, ROW, Gulf Country Council and QP release